A Defensive Dividend Aristocrat Poised for Strategic CatalystsSynthesized Investment Thesis for Medtronic (MDT): A Defensive Dividend Aristocrat Poised for Strategic Catalysts
Medtronic's recent market outperformance amidst broader volatility highlights its status as a defensive, high-quality holding within the healthcare sector. The stock represents a compell
Key facts today
Medtronic has received FDA clearance for its Stealth Axis™ Surgical System, marking it as the first integrated planning, navigation, and robotics platform specifically designed for spine surgery.
0.75 USD
3.94 B USD
28.35 B USD
About Medtronic plc.
Sector
Industry
CEO
Geoffrey Straub Martha
Website
Headquarters
Galway
Founded
2014
IPO date
Nov 21, 1977
Identifiers
2
ISIN ARDEUT111283
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Related stocks
Beautiful HH HL. MDT Analysis
Closed at 102.90 (07-02-2026)
Beautiful HH HL.
Weekly Candle is Doji. So next few candles
should be monitored.
Sustaining 101 - 102 may confirms the Breakout &
we may witness ABCD pattern targeting around 115 - 116
after crossing 106 with Good Volumes.
However, breaking 95 may bring m
Can a Medical Giant Transform Into a Growth Story?Medtronic has demonstrated significant momentum entering 2026, with its recent 23% share price appreciation reflecting fundamental improvements rather than speculative enthusiasm. The company delivered strong fiscal Q2 2026 results with revenue reaching approximately $9 billion, up 6.6% year-over-ye
MDT | Monster Rally Incoming!!! | LONGMedtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes
MDT Earnings Explosion – 95C Call for Big Gains!
# 💉 MDT Earnings Call Option – 95C Play (8/21 BMO)
📊 **Market Snapshot**
* Revenue Growth: +3.9% TTM
* Margins: Profit 13.9%, Operating 17.1%, Gross 65.4%
* Earnings Beat History: 100% past 8 quarters ✅
* Forward EPS: \$5.85 → ambitious 62% growth expectation
* Technical Support/Resistance: \$92
Chartamentals (Charting + Fundamentals) : #MDTPrice-to-Earnings (P/E): 16.33; Trailing P/E is moderate, below medical device industry average (20–25).
Price-to-Operating Cash Flow: ~10–12 (estimated); Not explicitly provided, reasonable for strong cash flow generation.
Strategic Advantage: Global leader in heart devices, spinal products, insuli
Medtronic Stock Chart Fibonacci Analysis 042925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 83.2/61.80%
Chart time frame:B
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
MDT4099940
Medtronic, Inc. 4.625% 15-MAR-2044Yield to maturity
5.71%
Maturity date
Mar 15, 2044
MDT3831466
Medtronic, Inc. 4.5% 15-MAR-2042Yield to maturity
5.33%
Maturity date
Mar 15, 2042
MDT3983800
Medtronic, Inc. 4.0% 01-APR-2043Yield to maturity
5.31%
Maturity date
Apr 1, 2043
MDT.GO
Medtronic, Inc. 5.55% 15-MAR-2040Yield to maturity
5.26%
Maturity date
Mar 15, 2040
MDT4284342
Medtronic, Inc. 4.625% 15-MAR-2045Yield to maturity
5.21%
Maturity date
Mar 15, 2045
MDT.GM
Medtronic, Inc. 6.5% 15-MAR-2039Yield to maturity
5.18%
Maturity date
Mar 15, 2039
MDT3673737
Covidien International Finance SA 6.55% 15-OCT-2037Yield to maturity
5.12%
Maturity date
Oct 15, 2037
MDT4284341
Medtronic, Inc. 4.375% 15-MAR-2035Yield to maturity
4.54%
Maturity date
Mar 15, 2035
XS283436845
Medtronic, Inc. 4.15% 15-OCT-2053Yield to maturity
4.48%
Maturity date
Oct 15, 2053
XS223879268
Medtronic Global Holdings S.C.A. 1.625% 15-OCT-2050Yield to maturity
4.39%
Maturity date
Oct 15, 2050
XS202067115
Medtronic Global Holdings S.C.A. 1.75% 02-JUL-2049Yield to maturity
4.37%
Maturity date
Jul 2, 2049
See all MDTC bonds









